• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Neuropeptide B (NPB)

ACP04940

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP04940 Target NameNPB
Target SynonymsNPB; PPL7; PPNPB; Neuropeptide B; Preproprotein L7; hPPL7) [Cleaved into: Neuropeptide B-23; NPB23; hL7); Neuropeptide B-29; NPB29; hL7C)]FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range25-53aa
Mol Weight29.5 kDaProtein LengthFull Length of Mature Protein
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8NG41
Background Information
  • Uniprot Id

    Q8NG41

  • Target Species

    Human

  • Target Name

    NPB

  • Target Full Name

    Neuropeptide B

  • Target Function

    May be involved in the regulation of feeding, neuroendocrine system, memory, learning and in the afferent pain pathway.

  • Target Subcellular Location

    Secreted.

  • Target Protein Families

    Neuropeptide B/W family

  • Target Tissue Specificity

    Widely expressed in the central nervous system. High levels are found in substantia nigra, hypothalamus, hyppocampus, spinal cord, placenta and fetal brain; lower levels are found in testis, uterus and ovary. Also detected at high levels in colorectal ade

  • Target Research Area

    Metabolism

  • Target Synonyms

    NPB; PPL7; PPNPB; Neuropeptide B; Preproprotein L7; hPPL7) [Cleaved into: Neuropeptide B-23; NPB23; hL7); Neuropeptide B-29; NPB29; hL7C)]

Inquire Recombinant Human Neuropeptide B (NPB) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification